Associate Members

  • AMEGI
  • GBMA
  • MOPI
  • PROGENERICOS
Mexican Association of Generic Medicines Read More
Generic and Biosimilar Medicines Association (Australia) Read More
Malaysian Organisation of Pharmaceutical Industries Read More
Brazilian Generic Medicine Drugmakers Association Read More

Print

Vision and Mission

Vision

Our vision is to promote the widest possible access to generic and biosimilar medicines with high quality, safety and efficacy, support international harmonized pathways for the registration of those medicines, and a strong commitment by members to standards agreed by the International Council for Harmonization (ICH) and WHO accredited regulators.

Mission

We endeavour to be the global voice of the generic and biosimilar medicines industries and, while promoting the highest GMP and GCP standards, cooperate to remove trade barriers that hinder commercial distribution of medicines across regional and international boundaries.

Goals

Promote regulatory cooperation and convergence of requirements for approval of generic and biosimilar medicines through international regulatory conferences /fora and trade negotiations.

Promote the widest possible access of medicines with high quality, safety and efficacy to patients globally.

Promote intellectual property regimes which foster innovation and allow timely launch of generic and biosimilar medicines, while supporting fair competition and preventing risks of IP abuses globally.

Be a representative body for global Generic and Biosimilar industries by attracting the widest assembly of members who are committed to subscribing to our standards and principles.

Represent our members and support and co-operate with relevant international bodies and initiatives including the WHO, WTO, WIPO, ICH, IGDRP, IPRF, etc.

Support parties in international and regional agreement negotiations to remove barriers and facilitate the registration and supply of generic and biosimilar medicines.

Foster the sustainability of medicine manufacturers in the interests of healthcare systems and patients.

Advance better access to generic and biosimilar medicines globally by organizing international conferences for the industry, stakeholders and regulators.

 

Joint 23rd Medicines for Europe and 20th IGBA Annual Conference

Joint 22nd Medicines for Europe and 19th IGBA Annual Conference

18th Annual IGPA Conference

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

Rue d'Arlon, 50
B-1000 Brussels, Belgium

Telephone: +32 (0)2 736 84 11
Fax: +32 (0)2 736 74 38
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.